Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Opening in 2016, the Museum Will Explore the African American Experience and How It Helped Shape American History and Culture. DUBLIN - Oct. 21, 2015 - Medtronic (NYSE: MDT) today announced that...
-
Diagnosing AF with Visia AF(TM) and Visia AF MRI(TM) SureScan® ICDs Enables Physicians to Manage Patients at Increased Risk for Stroke and Heart Failure DUBLIN - October 21, 2015 - Medtronic plc...
-
Pillsbury United Communities, Regions Hospital Foundation, HealthFinders Collaborative Will Implement "HealthRise" in Minnesota, One of Four Projects in the World. MINNEAPOLIS - October 19, 2015...
-
DUBLIN and CHICAGO - October 15, 2015 - Medtronic plc (NYSE: MDT) today announced favorable seven-year data maintaining improved clinical outcomes and patient satisfaction for the Prestige LP(TM)...
-
Presented at TCT and Published in JACC, Two-Year Outcomes Reinforce IN.PACT Admiral's Durability, Consistency and Safety as a Best-in-Class Treatment Option for PAD DUBLIN and SAN FRANCSICO -...
-
New Data Released at TCT 2015 Affirms Strong Performance of Recapturable and Repositionable Heart Valve Yielding Low Rates of Mortality and Stroke with Excellent Hemodynamics DUBLIN and SAN...
-
New Data Show Low Mortality and Improved Quality of Life for Patients with Failed Surgical Aortic Valves, End-Stage Renal Disease and Low Gradient Aortic Stenosis DUBLIN and SAN FRANCISCO -...
-
First Self-Expanding Valve Data from the STS/ACC TVT Registry Shows Outcomes in Everyday Clinical Practice at 30 Days are Consistent with the CoreValve U.S. Pivotal Trial DUBLIN and SAN FRANCISCO...
-
Collaboration Between Harvard Business Review and The New England Journal of Medicine Sponsored by Medtronic DUBLIN - October 12, 2015 - As communities around the world increasingly adopt programs...
-
Presented for the First Time at TCT, Early Results from the RevElution Trial Demonstrate Early Vessel Healing and Controlled, Polymer-Free Drug Elution in Patients Treated with the Novel...